We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$437M
AUM Growth
+$30.2M
Cap. Flow
+$3.43M
Cap. Flow %
0.78%
Top 10 Hldgs %
24.44%
Holding
187
New
7
Increased
67
Reduced
70
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.88M
2
IBM icon
IBM
IBM
+$2.54M
3
GE icon
GE Aerospace
GE
+$1.57M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$846K
5
UNH icon
UnitedHealth
UNH
+$594K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.28M
2
NVS icon
Novartis
NVS
+$2.2M
3
BA icon
Boeing
BA
+$1.69M
4
PFE icon
Pfizer
PFE
+$1.27M
5
AAPL icon
Apple
AAPL
+$529K

Sector Composition

Rank Sector Weight
1 Financials 15.2%
2 Technology 13.51%
3 Healthcare 13.47%
4 Consumer Discretionary 11.17%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
151
Comcast
CMCSA
$84.9B
$219K 0.05%
+5,460
New +$205K
USB.PRH icon
152
US Bancorp Series B Preferred Stock
USB.PRH
$750M
$215K 0.05%
+9,525
New +$219K
FAST icon
153
Fastenal
FAST
$51.4B
$214K 0.05%
15,688
-2,004
-11% -$24.8K
ZBH icon
154
Zimmer Biomet
ZBH
$17.4B
$214K 0.05%
+1,827
New +$207K
NEE icon
155
NextEra Energy
NEE
$184B
$213K 0.05%
+5,464
New +$211K
BAX icon
156
Baxter International
BAX
$11.4B
$210K 0.05%
3,250
– –
GLD icon
157
SPDR Gold Trust
GLD
$129B
$203K 0.05%
+1,640
New +$199K
LLY icon
158
Eli Lilly
LLY
$1.02T
$200K 0.05%
+2,373
New +$202K
PHYS icon
159
Sprott Physical Gold
PHYS
$14.4B
$157K 0.04%
14,850
-2,000
-12% -$20.8K
DMK
160
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$143K 0.03%
464
– –
MITK icon
161
Mitek Systems
MITK
$844M
$130K 0.03%
14,500
– –
CYRXW
162
DELISTED
CryoPort, Inc. Warrants
CYRXW
$55K 0.01%
10,000
-10,000
-50% -$44.4K
JYNT icon
163
The Joint Corp
JYNT
$124M
$50K 0.01%
10,000
-10,000
-50% -$49.7K
PLM
164
DELISTED
PolyMet Mining Corp.
PLM
$36K 0.01%
4,190
– –
JAGX icon
165
Jaguar Health
JAGX
$6.19M
– –
0
– –
BMO icon
166
Bank of Montreal
BMO
$125B
– –
-2,760
Closed -$209K
FIS icon
167
Fidelity National Information Services
FIS
$21.8B
– –
-2,250
Closed -$210K
LODE icon
168
Comstock
LODE
$294M
– –
-240
Closed -$9K
LOW icon
169
Lowe's Companies
LOW
$115B
– –
-3,785
Closed -$303K
NOBL icon
170
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
– –
-7,306
Closed -$217K
NVS icon
171
Novartis
NVS
$285B
– –
-28,606
Closed -$2.2M
NWL icon
172
Newell Brands
NWL
$2.18B
– –
-5,050
Closed -$215K
ORCL icon
173
Oracle
ORCL
$350B
– –
-4,149
Closed -$201K
3 4 5 6
7

Similar funds

SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return

Stonebridge Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Stonebridge Capital Advisors held 187 positions worth $437M, up 7.4% from $407M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors's Q4 2017 filing shows 7 new, 67 increased, 70 reduced and 10 closed positions. Its largest new stake was Caterpillar: 1,734 shares worth $273K. The largest sale was AbbVie, an estimated $2.28M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Stonebridge Capital Advisors's largest Q4 2017 buy was Caterpillar: 1,734 shares worth $273K.
  • Stonebridge Capital Advisors added most to Medtronic in Q4 2017, an estimated $4.88M increase.
  • Stonebridge Capital Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $2.28M.
  • Stonebridge Capital Advisors fully exited Novartis in Q4 2017, selling an estimated $2.2M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $437M portfolio in Q4 2017.
  • Stonebridge Capital Advisors opened 7 new positions and closed 10 in Q4 2017.
  • Stonebridge Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $437M.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2017, filed 15 Feb 2018.